Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 66

    1.

    Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting.

    Zazzi M, Prosperi M, Vicenti I, Di Giambenedetto S, Callegaro A, Bruzzone B, Baldanti F, Gonnelli A, Boeri E, Paolini E, Rusconi S, Giacometti A, Maggiolo F, Menzo S, De Luca A; ARCA Collaborative Group.

    J Antimicrob Chemother. 2009 Sep;64(3):616-24. Epub 2009 Jul 19.PMID: 19620134 [PubMed - indexed for MEDLINE]Related articles

    2.

    Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

    d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

    Clin Infect Dis. 2009 Aug 15;49(4):612-22.PMID: 19591597 [PubMed - indexed for MEDLINE]Related articles

    3.

    Increasing clinical virulence in two decades of the Italian HIV epidemic.

    Müller V, Maggiolo F, Suter F, Ladisa N, De Luca A, Antinori A, Sighinolfi L, Quiros-Roldan E, Carosi G, Torti C.

    PLoS Pathog. 2009 May;5(5):e1000454. Epub 2009 May 29.PMID: 19478880 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.

    Di Giambenedetto S, Zazzi M, Corsi P, Gonnelli A, Di Pietro M, Giacometti A, Almi P, Trezzi M, Boeri E, Gianotti N, Menzo S, Del Gobbo R, Francisci D, Nerli A, Galli L, De Luca A; Antiretroviral Resistance Cohort Analysis Study Group.

    Antivir Ther. 2009;14(3):359-69.PMID: 19474470 [PubMed - indexed for MEDLINE]Related articles

    5.

    Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

    Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, Macrae E, Maljkovic-Berry I, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen MO, Schmit JC, Schuurman R, Soriano V, Stanczak J, Stanojevic M, Struck D, Van Laethem K, Violin M, Yerly S, Zazzi M, Boucher CA, Vandamme AM; SPREAD Programme.

    Retrovirology. 2009 May 20;6:49.PMID: 19457244 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: 2 years of experience in routine clinical practice.

    Fabbiani M, Di Giambenedetto S, Bracciale L, Bacarelli A, Ragazzoni E, Cauda R, Navarra P, De Luca A.

    J Antimicrob Chemother. 2009 Jul;64(1):109-17. Epub 2009 Apr 27.PMID: 19398461 [PubMed - indexed for MEDLINE]Related articles

    7.

    Robust supervised and unsupervised statistical learning for HIV type 1 coreceptor usage analysis.

    Prosperi MC, Fanti I, Ulivi G, Micarelli A, De Luca A, Zazzi M.

    AIDS Res Hum Retroviruses. 2009 Mar;25(3):305-14.PMID: 19327050 [PubMed - indexed for MEDLINE]Related articles

    8.

    Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction?

    Bracciale L, Santangelo R, Fanti I, Prosperi M, Colafigli M, Di Giambenedetto S, Marchetti S, Di Franco A, Cauda R, De Luca A.

    Antivir Ther. 2009;14(1):99-101.PMID: 19320242 [PubMed - indexed for MEDLINE]Related articles

    9.

    Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1.

    Bracciale L, Di Giambenedetto S, Colafigli M, La Torre G, Prosperi M, Santangelo R, Marchetti S, Cauda R, Fadda G, De Luca A.

    AIDS Res Hum Retroviruses. 2009 Mar;25(3):261-7.PMID: 19292594 [PubMed - indexed for MEDLINE]Related articles

    10.

    Stochastic modelling of genotypic drug-resistance for human immunodeficiency virus towards long-term combination therapy optimization.

    Prosperi MC, D'Autilia R, Incardona F, De Luca A, Zazzi M, Ulivi G.

    Bioinformatics. 2009 Apr 15;25(8):1040-7. Epub 2008 Oct 31.PMID: 18977781 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

    Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CA, Cooper DA, Schapiro JM.

    AIDS. 2008 Oct 18;22(16):2053-67. Review. No abstract available. PMID: 18753937 [PubMed - indexed for MEDLINE]Related articles

    12.

    Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.

    De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, Marra CM, Antinori A; Gesida 9/99, IRINA, ACTG 363 Study Groups.

    AIDS. 2008 Sep 12;22(14):1759-67.PMID: 18753934 [PubMed - indexed for MEDLINE]Related articles

    13.

    Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores.

    Grant P, Wong EC, Rode R, Shafer R, De Luca A, Nadler J, Hawkins T, Cohen C, Harrington R, Kempf D, Zolopa A.

    Antimicrob Agents Chemother. 2008 Nov;52(11):4050-6. Epub 2008 Aug 18.PMID: 18710915 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation.

    Antinori A, Trotta MP, Lorenzini P, Torti C, Gianotti N, Maggiolo F, Ceccherini-Silberstein F, Nasto P, Castagna A, De Luca A, Mussini C, Andreoni M, Perno CF; GNOMO Study Group.

    Antivir Ther. 2007;12(8):1175-83.PMID: 18240858 [PubMed - indexed for MEDLINE]Related articles

    15.

    Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.

    De Luca A, Giambenedetto SD, Trotta MP, Colafigli M, Prosperi M, Ruiz L, Baxter J, Clevenbergh P, Cauda R, Perno CF, Antinori A.

    J Infect Dis. 2007 Dec 1;196(11):1645-53. Epub 2007 Oct 26.PMID: 18008248 [PubMed - indexed for MEDLINE]Related articles

    16.

    Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.

    Marzocchetti A, Sanguinetti M, Giambenedetto SD, Cingolani A, Fadda G, Cauda R, De Luca A.

    J Neurovirol. 2007 Aug;13(4):338-46.PMID: 17849317 [PubMed - indexed for MEDLINE]Related articles

    17.

    Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study.

    Di Giambenedetto S, Bracciale L, Colafigli M, Cattani P, Pinnetti C, Bacarelli A, Prosperi M, Fadda G, Cauda R, De Luca A.

    Antivir Ther. 2007;12(5):835-9. Erratum in: Antivir Ther. 2007;12(7):1145. Colatigli, Manuela [corrected to Colafigli, Manuela; Cattani, Paola [added]; Pannetti, Carmen [corrected to Pinnetti, Carmen]. PMID: 17713168 [PubMed - indexed for MEDLINE]Related articles

    18.

    Genotypic resistance to lopinavir and fosamprenavir with or without ritonavir of clinical isolates from patients failing protease inhibitors-containing HAART regimens: prevalence and predictors.

    Di Giambenedetto S, Bacarelli A, Pinnetti C, Colafigli M, Prosperi M, Gatti G, Cauda R, De Luca A.

    Scand J Infect Dis. 2007;39(9):813-8.PMID: 17701721 [PubMed - indexed for MEDLINE]Related articles

    19.

    Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?

    Bongiovanni M, Gori A, Lepri AC, Antinori A, de Luca A, Pagano G, Chiodera A, Puoti M, Monforte A; Italian Cohort of Antiretroviral-Naive Patients Study Group.

    Clin Infect Dis. 2007 Sep 1;45(5):650-3. Epub 2007 Aug 1.PMID: 17683003 [PubMed - indexed for MEDLINE]Related articles

    20.

    A whole-genome association study of major determinants for host control of HIV-1.

    Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, Cozzi-Lepri A, De Luca A, Easterbrook P, Francioli P, Mallal S, Martinez-Picado J, Miro JM, Obel N, Smith JP, Wyniger J, Descombes P, Antonarakis SE, Letvin NL, McMichael AJ, Haynes BF, Telenti A, Goldstein DB.

    Science. 2007 Aug 17;317(5840):944-7. Epub 2007 Jul 19.PMID: 17641165 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data

    Search details

    » See more...